Neuberger Berman Group’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.22M Buy
+95,805
New +$4.14M ﹤0.01% 1164

Other funds holding RAPP

Neuberger Berman Group's RAPP Position: Q3 2026 in Review

Neuberger Berman Group opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 95,805 shares worth $3.22M. The stake represents ﹤0.01% of the portfolio and ranks #1164 among its holdings.

168 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • Neuberger Berman Group held 95,805 shares of Rapport Therapeutics worth $3.22M as of Q3 2026.
  • Rapport Therapeutics was a new Neuberger Berman Group position in Q3 2026.
  • Rapport Therapeutics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #1164 holding.
  • 168 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.